Cardiovascular Systems Inc financial data

Industry
Surgical & Medical Instruments & Apparatus
Location
1225 Old Hwy 8 Nw, St. Paul, Minnesota
State of incorporation
Delaware
Fiscal year end
June 30
Former names
REPLIDYNE INC (to 3/3/2009)

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 587 % +3.09%
Quick Ratio 91.4 % +33.1%
Debt-to-equity 29 % +5.03%
Return On Equity -15.4 % -41.7%
Return On Assets -11.9 % -40.2%
Operating Margin -16.1 % -48.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 42 M shares +3.4%
Common Stock, Shares, Outstanding 42 M shares +3.37%
Common Stock, Value, Issued 40 K USD +2.56%
Weighted Average Number of Shares Outstanding, Basic 39.7 M shares +1.18%
Weighted Average Number of Shares Outstanding, Diluted 39.7 M shares +1.18%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 240 M USD -4.74%
Cost of Revenue 66.2 M USD -1.21%
Research and Development Expense 36.4 M USD -11.8%
Operating Income (Loss) -38.6 M USD -41.6%
Nonoperating Income (Expense) 836 K USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -37.7 M USD -32.1%
Income Tax Expense (Benefit) 141 K USD -56.6%
Net Income (Loss) Attributable to Parent -37.9 M USD -31.1%
Earnings Per Share, Basic -0.96 USD/shares -28%
Earnings Per Share, Diluted -0.96 USD/shares +13%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 59.8 M USD -9.14%
Marketable Securities, Current 72.2 M USD -34.8%
Accounts Receivable, after Allowance for Credit Loss, Current 40.2 M USD +15.1%
Inventory, Net 41.2 M USD +30.1%
Assets, Current 222 M USD -10.5%
Property, Plant and Equipment, Net 30 M USD +2.06%
Operating Lease, Right-of-Use Asset 1.64 M USD -19.6%
Other Assets, Noncurrent 2.47 M USD -15.3%
Assets 312 M USD -4.56%
Accounts Payable, Current 17.1 M USD +36.8%
Accrued Liabilities, Current 19.1 M USD -28.2%
Contract with Customer, Liability, Current 991 K USD -12.2%
Liabilities, Current 36.8 M USD -12.2%
Operating Lease, Liability, Noncurrent 1.11 M USD -27%
Other Liabilities, Noncurrent 11.9 M USD +214%
Liabilities 72.1 M USD +7.84%
Accumulated Other Comprehensive Income (Loss), Net of Tax -170 K USD -193%
Retained Earnings (Accumulated Deficit) -443 M USD -9.72%
Stockholders' Equity Attributable to Parent 239 M USD -7.76%
Liabilities and Equity 312 M USD -4.56%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -13.7 M USD -26.6%
Net Cash Provided by (Used in) Financing Activities -1.26 M USD +74.9%
Net Cash Provided by (Used in) Investing Activities 11.3 M USD -2.31%
Common Stock, Shares Authorized 100 M shares 0%
Common Stock, Shares, Issued 42 M shares +3.37%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.57 M USD +15%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 59.8 M USD -9.14%
Operating Lease, Liability 1.64 M USD -19.6%
Depreciation 874 K USD -8.39%
Payments to Acquire Property, Plant, and Equipment 688 K USD -37.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -38 M USD -30.8%
Lessee, Operating Lease, Liability, to be Paid 1.71 M USD -20.5%
Property, Plant and Equipment, Gross 57 M USD +7.95%
Operating Lease, Liability, Current 522 K USD +2.35%
Lessee, Operating Lease, Liability, to be Paid, Year Two 503 K USD +2.86%
Lessee, Operating Lease, Liability, to be Paid, Year One 514 K USD 0%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 71 K USD -37.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 416 K USD -13.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 4 K USD -99%
Amortization of Intangible Assets 1.38 M USD +9.94%
Interest Expense 1.63 M USD -1.1%